ExodusPoint Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-145,355
| Closed | -$9.85M | – | 1393 |
|
|
2024
Q1 | $9.85M | Buy |
145,355
+49,674
| +52% | +$3.37M | 0.08% | 175 |
|
|
2023
Q4 | $6.44M | Sell |
95,681
-155,500
| -62% | -$10.5M | 0.04% | 260 |
|
|
2023
Q3 | $17M | Buy |
251,181
+231,042
| +1,147% | +$15.6M | 0.16% | 100 |
|
|
2023
Q2 | $1.44M | Sell |
20,139
-202,787
| -91% | -$14.5M | 0.01% | 866 |
|
|
2023
Q1 | $15.5M | Buy |
+222,926
| New | +$15.5M | 0.13% | 143 |
|
|
2022
Q4 | – | Sell |
-57,915
| Closed | -$3.18M | – | 1579 |
|
|
2022
Q3 | $3.18M | Buy |
+57,915
| New | +$3.18M | 0.04% | 541 |
|
|
2022
Q2 | – | Sell |
-6,126
| Closed | -$406K | – | 1877 |
|
|
2022
Q1 | $406K | Sell |
6,126
-394
| -6% | -$26.1K | 0.01% | 1584 |
|
|
2021
Q4 | $380K | Sell |
6,520
-67,163
| -91% | -$3.91M | ﹤0.01% | 1516 |
|
|
2021
Q3 | $4.43M | Buy |
73,683
+10,091
| +16% | +$606K | 0.06% | 405 |
|
|
2021
Q2 | $3.81M | Buy |
+63,592
| New | +$3.81M | 0.04% | 406 |
|
|
2021
Q1 | – | Sell |
-16,811
| Closed | -$840K | – | 2057 |
|
|
2020
Q4 | $840K | Sell |
16,811
-4,227
| -20% | -$211K | 0.01% | 893 |
|
|
2020
Q3 | $1.15M | Buy |
21,038
+15,001
| +248% | +$822K | 0.02% | 572 |
|
|
2020
Q2 | $319K | Buy |
+6,037
| New | +$319K | 0.01% | 1267 |
|
|
2019
Q3 | – | Sell |
-14,013
| Closed | -$578K | – | 1302 |
|
|
2019
Q2 | $578K | Buy |
14,013
+2,919
| +26% | +$120K | 0.02% | 381 |
|
|
2019
Q1 | $449K | Buy |
+11,094
| New | +$449K | 0.03% | 353 |
|